Hoe is Howard Berger's beloning veranderd ten opzichte van RadNet's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Sep 30 2024	n/a	n/a	-US$4m
Jun 30 2024	n/a	n/a	US$10m
Mar 31 2024	n/a	n/a	US$21m
Dec 31 2023	US$7m	US$2m	US$3m
Sep 30 2023	n/a	n/a	US$4m
Jun 30 2023	n/a	n/a	-US$13m
Mar 31 2023	n/a	n/a	-US$13m
Dec 31 2022	US$6m	US$2m	US$11m
Sep 30 2022	n/a	n/a	US$8m
Jun 30 2022	n/a	n/a	US$23m
Mar 31 2022	n/a	n/a	US$18m
Dec 31 2021	US$5m	US$1m	US$25m
Sep 30 2021	n/a	n/a	US$35m
Jun 30 2021	n/a	n/a	US$24m
Mar 31 2021	n/a	n/a	US$11m
Dec 31 2020	US$3m	US$783k	-US$15m
Sep 30 2020	n/a	n/a	-US$10m
Jun 30 2020	n/a	n/a	-US$13m
Mar 31 2020	n/a	n/a	US$2m
Dec 31 2019	US$3m	US$1m	US$15m
Sep 30 2019	n/a	n/a	US$33m
Jun 30 2019	n/a	n/a	US$35m
Mar 31 2019	n/a	n/a	US$36m
Dec 31 2018	US$3m	US$1m	US$32m

Compensatie versus markt: De totale vergoeding ($USD 6.70M ) Howard } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 6.63M ).

Compensatie versus inkomsten: De vergoeding van Howard is gestegen terwijl het bedrijf verliesgevend is.

CEO

Howard Berger (78 yo)

38yrs

Tenure

US$6,700,183

Compensatie

Dr. Howard G. Berger, M.D., serves as the President and Chief Financial Officer of Image Medical Corporation. Dr. Berger has been the Chief Executive Officer and President at RadNet, Inc. and its predecess...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Howard Berger	Chairman	38yrs	US$6.70m	0.17% $ 7.9m
Mark Stolper	Executive VP & CFO	20.5yrs	US$1.90m	0.14% $ 6.6m
A. Sorensen	Executive VP	1.4yrs	US$1.80m	1.71% $ 80.7m
Mital Patel	Executive VP of Financial Planning & Analysis and Chief Administrative Officer	4yrs	US$1.92m	0.31% $ 14.5m
Norman Hames	President & COO of Western Operations	no data	US$2.14m	0.32% $ 15.1m
Stephen Forthuber	President & COO of Eastern Operations	7.7yrs	US$2.16m	0.72% $ 34.0m
Ranjan Jayanathan	Executive VP	14.3yrs	geen gegevens	0.28% $ 13.0m
Laura Foster	Senior Vice President of Compliance & Regulatory Affairs	7.8yrs	geen gegevens	geen gegevens
David Katz	Executive VP	4.8yrs	geen gegevens	0.12% $ 5.6m
Michael Murdock	Executive Vice President of Mergers & Acquisitions	18yrs	geen gegevens	0.073% $ 3.5m
Derek Bomar	Senior VP & Director of Materials & Asset Management	22yrs	geen gegevens	geen gegevens
Charles Shaw	SVP of Healthcare Network Strategy & Business Development - Eastern Operations	7.4yrs	geen gegevens	geen gegevens

7.8yrs

Gemiddelde duur

62.5yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van RDNT is doorgewinterd en ervaren (gemiddelde ambtstermijn van 7.8 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Howard Berger	Chairman	33yrs	US$6.70m	0.17% $ 7.9m
A. Sorensen	Executive VP	1.4yrs	US$1.80m	1.71% $ 80.7m
David Swartz	Lead Independent Director	21yrs	US$244.99k	0.32% $ 15.0m
Gregory Spurlock	Independent Director	3.6yrs	US$207.49k	0.0035% $ 165.1k
Lawrence Levitt	Independent Director	20yrs	US$224.99k	0.23% $ 10.8m
Laura Jacobs	Independent Director	5yrs	US$222.49k	0.033% $ 1.5m

12.5yrs

Gemiddelde duur

72.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van RDNT zijn ervaren en ervaren (gemiddelde ambtstermijn van 12.5 jaar).

Bedrijfsanalyse en status van financiële gegevens

Gegevens	Laatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse	2025/01/23 06:36
Aandelenkoers aan het einde van de dag	2025/01/23 00:00
Inkomsten	2024/09/30
Jaarlijkse inkomsten	2023/12/31

Gegevensbronnen

De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.

Pakket	Gegevens	Tijdframe	Voorbeeld Amerikaanse bron ^*
Financiële gegevens bedrijf	10 jaar	Resultatenrekening Kasstroomoverzicht Balans	SEC-formulier 10-K SEC-formulier 10-Q
Consensus schattingen analisten	+3 jaar	Financiële prognoses Koersdoelen analisten	Onderzoeksrapporten van analisten Blue Matrix
Marktprijzen	30 jaar	Aandelenprijzen Dividenden, splitsingen en acties	ICE Marktgegevens SEC-formulier S-1
Eigendom	10 jaar	Top aandeelhouders Handel met voorkennis	SEC-formulier 4 SEC-formulier 13D
Beheer	10 jaar	Leiderschapsteam Raad van bestuur	SEC-formulier 10-K SEC-formulier DEF 14A
Belangrijkste ontwikkelingen	10 jaar	Bedrijfsaankondigingen	SEC-formulier 8-K

^* voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige regelgevingsformulieren en bronnen gebruikt.

Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Lees hier meer.

Analysemodel en Snowflake

Details van het analysemodel dat is gebruikt om dit rapport te genereren, zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen voor het gebruik van onze rapporten en tutorials op Youtube.

Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.

Industrie en sector

Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op .

Bronnen van analisten

RadNet, Inc. wordt gevolgd door 11 analisten. 4 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.

Analist	Instelling
Sarah James	Barclays
Andrew Mok	Barclays
Juan Molta	B. Riley Securities, Inc.

RadNet Beheer

Beheer criteriumcontroles 3/4

Belangrijke informatie

Recente managementupdates

RadNet, Inc. Appoints Cornelis “Kees” Wesdorp as President and Chief Executive Officer of its Digital Health Segment, Effective October 1, 2024

RadNet, Inc., Annual General Meeting, Jun 12, 2024

Insider recently sold US$354k worth of stock

Insider notifies of intention to sell stock

RadNet, Inc. Appoints Dr. Gregory Sorensen as Executive Vice President and Chief Science Officer

RadNet, Inc. Announces Appointment of Executives

Recent updates

Does RadNet (NASDAQ:RDNT) Have A Healthy Balance Sheet?

Is It Time To Consider Buying RadNet, Inc. (NASDAQ:RDNT)?

There's Reason For Concern Over RadNet, Inc.'s (NASDAQ:RDNT) Massive 26% Price Jump

RadNet, Inc. Revises Earnings Guidance for the Year 2024

Here's What To Make Of RadNet's (NASDAQ:RDNT) Decelerating Rates Of Return

RadNet: Secular Tailwinds Underpinned By AI Monetization Prospects

Unpleasant Surprises Could Be In Store For RadNet, Inc.'s (NASDAQ:RDNT) Shares

RadNet, Inc. Appoints Cornelis “Kees” Wesdorp as President and Chief Executive Officer of its Digital Health Segment, Effective October 1, 2024

RadNet: Growth In Operating Earnings Off Very Little Incremental Capital

RadNet (NASDAQ:RDNT) Seems To Use Debt Quite Sensibly

Returns On Capital At RadNet (NASDAQ:RDNT) Have Stalled

RadNet: Qualified Growth Route, Still Undervalued

Price target increased by 7.2% to US$57.17

Is There Now An Opportunity In RadNet, Inc. (NASDAQ:RDNT)?

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Now 23% overvalued after recent price rise

RadNet, Inc., Annual General Meeting, Jun 12, 2024

Price target increased by 7.0% to US$53.33

Are RadNet, Inc. (NASDAQ:RDNT) Investors Paying Above The Intrinsic Value?

Now 21% overvalued after recent price rise

RadNet, Inc. has completed a Follow-on Equity Offering in the amount of $200.2 million.

Consensus EPS estimates increase by 12%

RadNet, Inc.'s (NASDAQ:RDNT) 26% Price Boost Is Out Of Tune With Revenues

Price target increased by 12% to US$45.80

Now 21% overvalued after recent price rise

Full year 2023 earnings: EPS misses analyst expectations

Why RadNet, Inc. (NASDAQ:RDNT) Could Be Worth Watching

RadNet, Inc. Stock Price Is More Vigorous Than Its Valuation

Getting In Cheap On RadNet, Inc. (NASDAQ:RDNT) Might Be Difficult

Insider recently sold US$354k worth of stock

Insider notifies of intention to sell stock

RadNet, Inc. Launches a Pilot Inside Walmart of its New MammogramNow™ Offering

We Think RadNet (NASDAQ:RDNT) Can Stay On Top Of Its Debt

RadNet, Inc. Unveils DeepHealth, a Pioneering AI-Powered Health Informatics Portfolio

RadNet, Inc. Unveils DeepHealth, a Pioneering AI-Powered Health Informatics Portfolio

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

RadNet (NASDAQ:RDNT) Might Be Having Difficulty Using Its Capital Effectively

New major risk - Financial position

RadNet, Inc. Appoints Dr. Gregory Sorensen as Executive Vice President and Chief Science Officer

RadNet (NASDAQ:RDNT) Takes On Some Risk With Its Use Of Debt

Radnet, Inc. Revises Earnings Guidance for the Year 2023

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

RadNet, Inc. Announces Appointment of Executives

Consensus EPS estimates upgraded to US$0.10 loss

RadNet, Inc. has completed a Follow-on Equity Offering in the amount of $225.35625 million.

President & COO of Western Operations recently sold US$1.4m worth of stock

RadNet, Inc. Announces Ruth V. Wilson Did Not to Stand for Re-Election to the Board of Directors

President & COO of Western Operations exercised options to buy US$1.5m worth of stock.

RadNet, Inc., Annual General Meeting, Jun 07, 2023

Board Member recently sold US$138k worth of stock

RadNet, Inc. Revises Earnings Guidance for the Year 2023

Price target increased by 7.8% to US$34.50

We Think RadNet (NASDAQ:RDNT) Is Taking Some Risk With Its Debt

President & COO of Eastern Operations recently sold US$230k worth of stock

Insider recently sold US$443k worth of stock

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

RadNet (NASDAQ:RDNT) Will Want To Turn Around Its Return Trends

Radiology Imaging Associates Launches the Enhanced Breast Cancer Detection Program, Providing Women A New State-Of-The-Art Solution Powered by Artificial Intelligence

President & COO of Western Operations recently sold US$97k worth of stock

RadNet (NASDAQ:RDNT) Has A Somewhat Strained Balance Sheet

An Intrinsic Calculation For RadNet, Inc. (NASDAQ:RDNT) Suggests It's 41% Undervalued

Consensus forecasts updated

Third quarter 2022 earnings: EPS misses analyst expectations

RadNet, Inc. Provides Earnings Guidance for the Full Year of 2022

Investor sentiment deteriorated over the past week

RadNet, Inc. (NasdaqGM:RDNT) acquired 75% stake in Heart & Lung Imaging Limited.

RadNet JV acquires Montclair Radiology's outpatient radiology assets

Some Investors May Be Worried About RadNet's (NASDAQ:RDNT) Returns On Capital

Price target decreased to US$32.25